![Christina Coughlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christina Coughlin
Algemeen Directeur bij
AVACTA GROUP PLC
Vermogen: 87 471 $ op 31-05-2026
Profiel
Christina Marie Coughlin currently works at Avacta Group Plc, as Chief Executive Officer & Executive Director from 2024.
Dr. Coughlin also formerly worked at Cytoimmune Therapeutics, Inc., as Chief Executive Officer & Director from 2021 to 2023, Rubius Therapeutics, Inc., as Chief Medical Officer from 2020 to 2021, Tmunity Therapeutics, Inc., as Chief Medical Officer from 2018 to 2019, and Immunocore Holdings Plc, as Chief Medical Officer from 2015 to 2018.
Dr. Coughlin received her doctorate degree from the University of Pennsylvania and undergraduate degree from Temple University (Pennsylvania).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AVACTA GROUP PLC 0,02% | 05-06-2026 | 82.142 ( 0,02% ) | 87 471 $ | 31-05-2026 |
Actieve functies van Christina Coughlin
| Bedrijven | Functie | Begin |
|---|---|---|
| AVACTA GROUP PLC | Algemeen Directeur | 01-04-2024 |
Eerdere bekende functies van Christina Coughlin
| Bedrijven | Functie | Einde |
|---|---|---|
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Algemeen Directeur | 18-07-2023 |
| RUBIUS THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 12-11-2021 |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Hoofd Techniek/Wetenschap/O&O | 01-11-2019 |
| IMMUNOCORE HOLDINGS PLC | Hoofd Techniek/Wetenschap/O&O | 01-07-2018 |
Opleiding van Christina Coughlin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Cytoimmune Therapeutics, Inc.
Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cancer immunotherapy products | Health Technology |
